Westpac Banking Corporation »

Haemonetics Corporation shares owned by Westpac Banking Corporation

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Westpac Banking Corporation from 13F filings

Historical chart of Westpac Banking Corporation investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Westpac Banking Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Westpac Banking Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $287k 3.6k 80.15

More positions owned by Westpac Banking Corporation

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Citigroup Com New (C)
Tesla Motors (TSLA)
Goldman Sachs (GS)
Intuit (INTU)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Westpac Banking Corporation

Top funds holding Haemonetics Corporation

BlackRock
Vanguard Group
Neuberger Berman Group
AQR Capital Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Holocene Advisors
Royal Bank of Canada
FMR
Geode Capital Management
North Peak Capital Management
River Road Asset Management
Dimensional Fund Advisors
T. Rowe Price Investment Management

View all funds holding Haemonetics Corporation